Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Panel hears bill to ease refill rules for certain injectable testosterone prescriptions
Summary
House Bill 126 would allow some patients who have demonstrated consistent use to receive 92‑day supplies of certain injectable androgen prescriptions after a 12‑month period of monthly fills, reducing travel and prescription costs for patients, while adding a prescriber attestation as a safeguard.
Representative Popovici Mueller introduced House Bill 126, a bipartisan measure intended to reduce the burden on patients who receive injectable androgen prescriptions that are federally scheduled. The bill would add a provision to the Controlled Drug Act permitting a 92‑day supply after a patient has previously filled 12 monthly prescriptions from the same medical practice over a one‑year period; the prescription would need to include a…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
